Ro to offer lower-price vials of weight loss drug Zepbound
Amid new worries that legal copycats of the weight-loss drugs from Eli Lilly and Novo Nordisk could erode the market for the ...
Eli Lilly (LLY) has announced it will make lower-priced, single-dose vials of its popular weight-loss treatment Zepound ...
Through a new relationship with Eli Lilly, Ro patients can now get easier access to the drugmaker’s discounted, single-dose ...
Eli Lilly strikes Zepbound deal with the telehealth platform Ro, amid questions about future of compounded GLP-1s.
Rep. Ro Khanna (D-Calif.) said that there could be “huge bipartisan cooperation” for President-elect Trump’s Department of ...
I look forward to working with the Department of Government Efficiency (DOGE). There are several areas of waste and abuse ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning, hope everyone is ...
The partnership between Ro and Eli Lilly (LLY) to streamline access to Lilly’s GLP-1 Zepbound single-dose vials for Ro patients with obesity is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback